1. Pink Sheet
  2. >>Archive

Gleevec Could Get Higher Maximum Approved Dose

 
• By Andrew Kasper

Novartis is seeking to increase the maximum approved dose of its oncologic Gleevec (imatinib mesylate) to 800 mg, Oncology President David Epstein said Jan. 20

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet